Evaluating ultrasound elastography for diagnosing pleural effusion

The Effectiveness and Safety of Ultrasound Elastography Guided Pleural Biopsy in the Differential Diagnosis of Benign and Malignant Pleural Effusion

Not applicable Interventional China-Japan Friendship Hospital · NCT05781659

This study is testing if a new ultrasound technique for taking pleural biopsies can better tell the difference between harmless and harmful fluid in the lungs compared to the standard method for people with unexplained pleural effusion.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment592 (estimated)
Ages18 Years to 90 Years
SexAll
SponsorChina-Japan Friendship Hospital Academic / other
Locations9 sites (Hefei, Anhui and 8 other locations)
Trial IDNCT05781659 on ClinicalTrials.gov

What this trial studies

This clinical trial aims to assess the effectiveness and safety of ultrasound elastography guided pleural biopsy compared to traditional ultrasound-guided pleural biopsy in differentiating between benign and malignant pleural effusions. Participants with unexplained pleural effusion will undergo either of the two biopsy methods. The study will analyze diagnostic efficacy and safety outcomes to determine the best approach for accurate diagnosis.

Who should consider this trial

Good fit: Ideal candidates are patients with unexplained pleural effusion who have undergone necessary preliminary examinations.

Not a fit: Patients with cytological evidence of malignancy or severe pleural adhesion may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could improve diagnostic accuracy for patients with pleural effusion, leading to better treatment decisions.

How similar studies have performed: While similar diagnostic approaches have been explored, this specific use of ultrasound elastography for pleural biopsy is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients with unexplained pleural effusion (patients with pleural effusion with negative aspiration)
2. Sign the informed consent form
3. The patient must have chest CT, biochemical examination of pleural fluid, cytological examination of pleural fluid and other data before operation

Exclusion Criteria:

1. The cytological examination of pleural fluid indicates "highly suspicious" patients (unless the cytological examination results of patients are inconsistent with clinical manifestations and CT examination). The pleural fluid cytology proved to be malignant. Patients with severe pleural adhesion who cannot undergo medical thoracoscopic examination will not be randomly selected, and elastic ultrasound-guided biopsy can be performed after informed consent, as a subgroup of population analysis. Those who cannot tolerate closed pleural biopsy due to severe cardiopulmonary dysfunction and poor general condition Coagulation dysfunction. Leakage. The age is less than 18 years old.
2. The pleural fluid cytology proved to be malignant.
3. Patients with severe pleural adhesion who cannot undergo medical thoracoscopic examination will not be randomly selected, and elastic ultrasound-guided biopsy can be performed after informed consent, as a subgroup of population analysis.
4. Those who cannot tolerate closed pleural biopsy due to severe cardiopulmonary dysfunction and poor general condition
5. Coagulation dysfunction.
6. transudate
7. The age is less than 18 years old.

Where this trial is running

Hefei, Anhui and 8 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Pleural Effusion
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.